Lewey Jennifer, Choudhry Niteesh K
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA, 02120, USA.
Curr Cardiol Rep. 2014;16(10):530. doi: 10.1007/s11886-014-0530-3.
Significant racial/ethnic disparities have been documented in cardiovascular care. Although health care quality is improving for many Americans, differences in clinical outcomes have persisted between racial/ethnic minority patients and non-minorities, even when income, education level, and site of care are taken into consideration. Potential causes of disparities are complex and are related to differences in risk factor prevalence and control, use of evidence-based procedures and medications, and social and environmental factors. Minority patients are more likely to receive care from lower-quality health care providers and institutions and experience more barriers to accessing care. Factors such as stereotyping and bias in medicine are hard to quantify, but likely contribute to differences in treatment. Recent trends suggest that some disparities are decreasing. Opportunities for change and improvement exist for patients, providers, and health care systems. Promising interventions, such as health policy changes, quality improvement programs, and culturally targeted community and clinic-based interventions offer hope that high-quality health care in the USA can be provided to all patients.
心血管护理领域已记录到显著的种族/族裔差异。尽管许多美国人的医疗保健质量正在提高,但即使考虑到收入、教育水平和医疗地点,少数种族/族裔患者与非少数种族患者之间的临床结果差异依然存在。差异的潜在原因很复杂,与危险因素的流行率和控制情况、循证程序和药物的使用以及社会和环境因素的差异有关。少数种族患者更有可能接受质量较低的医疗保健提供者和机构的治疗,并且在获得医疗服务方面面临更多障碍。医学中的刻板印象和偏见等因素难以量化,但可能导致治疗差异。最近的趋势表明,一些差异正在缩小。患者、医疗服务提供者和医疗保健系统都存在变革和改进的机会。有前景的干预措施,如卫生政策变革、质量改进计划以及针对特定文化的社区和诊所干预措施,给在美国为所有患者提供高质量医疗保健带来了希望。